STOCKHOLDERS' EQUITY (DEFICIT) (Details 2) |
6 Months Ended |
|---|---|
|
Jun. 30, 2016
$ / shares
shares
| |
| Warrant exercise price | $ 4.50 |
| Warrants outstanding at end of period | shares | 5,000 |
| Weighted Average Remaining Contractual Life | 10 months 13 days |
| Weighted Average Exercise Price | $ 4.50 |
| Number exercisable at end of period | shares | 5,000 |
| Weighted Average Exercise Price | $ 4.50 |
| Warrant $4.50 [Member] | |
| Warrant exercise price | $ 4.50 |
| Warrants outstanding at end of period | shares | 5,000 |
| Weighted Average Remaining Contractual Life | 10 months 13 days |
| Weighted Average Exercise Price | $ 4.50 |
| Number exercisable at end of period | shares | 5,000 |
| Weighted Average Exercise Price | $ 4.50 |
| X | ||||||||||
- Definition Exercise price of the warrants. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Details
|